Resumen de acción 4007
Al Hammadi Holding Company, grupo sanitario, presta diversos servicios médicos en el Reino de Arabia Saudí.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Competidores de Al Hammadi Holding Company
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س56.30 |
| 52 Week High | ر.س71.80 |
| 52 Week Low | ر.س47.95 |
| Beta | 0.46 |
| 1 Month Change | -1.05% |
| 3 Month Change | -8.90% |
| 1 Year Change | 6.43% |
| 3 Year Change | 120.46% |
| 5 Year Change | 207.65% |
| Change since IPO | 289.96% |
Noticias y actualizaciones recientes
Investor Optimism Abounds Al Hammadi Holding Company (TADAWUL:4007) But Growth Is Lacking
Apr 23
Al Hammadi Holding (TADAWUL:4007) Is Paying Out A Dividend Of SAR0.35
Mar 25Recent updates
Investor Optimism Abounds Al Hammadi Holding Company (TADAWUL:4007) But Growth Is Lacking
Apr 23Al Hammadi Holding (TADAWUL:4007) Is Paying Out A Dividend Of SAR0.35
Mar 25The Return Trends At Al Hammadi Holding (TADAWUL:4007) Look Promising
Feb 08Should You Be Adding Al Hammadi Holding (TADAWUL:4007) To Your Watchlist Today?
Jan 18There's Reason For Concern Over Al Hammadi Holding Company's (TADAWUL:4007) Price
Dec 28Should You Be Adding Al Hammadi Holding (TADAWUL:4007) To Your Watchlist Today?
Oct 19We Like These Underlying Return On Capital Trends At Al Hammadi Holding (TADAWUL:4007)
Sep 23If EPS Growth Is Important To You, Al Hammadi Holding (TADAWUL:4007) Presents An Opportunity
Jul 19There's Been No Shortage Of Growth Recently For Al Hammadi Holding's (TADAWUL:4007) Returns On Capital
Jun 19Here's Why We Think Al Hammadi Holding (TADAWUL:4007) Is Well Worth Watching
Apr 14Returns On Capital Are Showing Encouraging Signs At Al Hammadi Holding (TADAWUL:4007)
Mar 09Here's Why We Think Al Hammadi Holding (TADAWUL:4007) Might Deserve Your Attention Today
Jan 06Are Investors Undervaluing Al Hammadi Holding Company (TADAWUL:4007) By 30%?
Oct 25Does Al Hammadi Holding (TADAWUL:4007) Deserve A Spot On Your Watchlist?
Sep 14Is There An Opportunity With Al Hammadi Company For Development and Investment's (TADAWUL:4007) 46% Undervaluation?
Jul 22Al Hammadi Company For Development and Investment's (TADAWUL:4007) Returns On Capital Are Heading Higher
Jul 05Here's Why I Think Al Hammadi Company For Development and Investment (TADAWUL:4007) Might Deserve Your Attention Today
Jun 10Al Hammadi Company For Development and Investment (TADAWUL:4007) Is Looking To Continue Growing Its Returns On Capital
Mar 09This Analyst Just Downgraded Their Al Hammadi Company For Development and Investment (TADAWUL:4007) EPS Forecasts
Feb 02I Ran A Stock Scan For Earnings Growth And Al Hammadi Company For Development and Investment (TADAWUL:4007) Passed With Ease
Jan 17Returns On Capital At Al Hammadi Company For Development and Investment (TADAWUL:4007) Have Stalled
Nov 17Estimating The Fair Value Of Al Hammadi Company For Development and Investment (TADAWUL:4007)
Sep 23If You Like EPS Growth Then Check Out Al Hammadi Company For Development and Investment (TADAWUL:4007) Before It's Too Late
Aug 10The Returns At Al Hammadi Company For Development and Investment (TADAWUL:4007) Aren't Growing
Jul 20Read This Before Buying Al Hammadi Company For Development and Investment (TADAWUL:4007) For Its Dividend
May 03Slowing Rates Of Return At Al Hammadi Company For Development and Investment (TADAWUL:4007) Leave Little Room For Excitement
Apr 20Calculating The Fair Value Of Al Hammadi Company For Development and Investment (TADAWUL:4007)
Apr 05What Percentage Of Al Hammadi Company For Development and Investment (TADAWUL:4007) Shares Do Insiders Own?
Mar 19I Ran A Stock Scan For Earnings Growth And Al Hammadi Company For Development and Investment (TADAWUL:4007) Passed With Ease
Mar 04Al Hammadi Company For Development and Investment (TADAWUL:4007) Share Prices Have Dropped 30% In The Last Five Years
Feb 17
Is Al Hammadi Company For Development and Investment's (TADAWUL:4007) Stock On A Downtrend As A Result Of Its Poor Financials?
Feb 02Here's What To Make Of Al Hammadi Company For Development and Investment's (TADAWUL:4007) Returns On Capital
Jan 17Estimating The Intrinsic Value Of Al Hammadi Company For Development and Investment (TADAWUL:4007)
Jan 01Could The Al Hammadi Company For Development and Investment (TADAWUL:4007) Ownership Structure Tell Us Something Useful?
Dec 16If You Like EPS Growth Then Check Out Al Hammadi Company For Development and Investment (TADAWUL:4007) Before It's Too Late
Dec 01Rentabilidad de los accionistas
| 4007 | SA Healthcare | Mercado SA | |
|---|---|---|---|
| 7D | -2.4% | -1.2% | -0.2% |
| 1Y | 6.4% | 15.1% | -0.6% |
Rentabilidad vs. Industria: 4007 obtuvo unos resultados inferiores a los del sector SA Healthcare , que el año pasado arrojó un rendimiento del 14.6%.
Rentabilidad vs. Mercado: 4007 superó al mercado SA, que obtuvo un rendimiento del 0.7% el año pasado.
Volatilidad de los precios
| 4007 volatility | |
|---|---|
| 4007 Average Weekly Movement | 4.5% |
| Healthcare Industry Average Movement | 4.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in SA Market | 7.9% |
| 10% least volatile stocks in SA Market | 2.6% |
Precio estable de las acciones: 4007 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 4007 (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1985 | n/a | Mohammad Bin Saleh Bin Al Hammadi | www.alhammadi.com |
Al Hammadi Holding Company, grupo sanitario, presta diversos servicios médicos en el Reino de Arabia Saudí. La empresa opera a través de los segmentos de Servicios Médicos y Productos Farmacéuticos. Se dedica a la venta de productos farmacéuticos.
Resumen de fundamentos de Al Hammadi Holding Company
| Estadísticas fundamentales de 4007 | |
|---|---|
| Capitalización bursátil | ر.س9.01b |
| Beneficios(TTM) | ر.س303.33m |
| Ingresos (TTM) | ر.س1.18b |
29.7x
Ratio precio-beneficio (PE)7.7x
Ratio precio-ventas (PS)¿Está 4007 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 4007 | |
|---|---|
| Ingresos | ر.س1.18b |
| Coste de los ingresos | ر.س744.16m |
| Beneficio bruto | ر.س432.60m |
| Otros gastos | ر.س129.27m |
| Beneficios | ر.س303.33m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 1.90 |
| Margen bruto | 36.76% |
| Margen de beneficio neto | 25.78% |
| Ratio deuda/patrimonio | 10.4% |
¿Cómo se ha desempeñado 4007 a largo plazo?
Ver rendimiento histórico y comparativa